BioWorld MedTech

June 15, 2011

CerebralRx enters market with vagus nerve stimulation device

CerebralRx, a newly formed spin-off of BioControl Medical (both Yehud, Israel), is hitting the ground running with the launch of its FitNeS vagus nerve stimulation system for epilepsy in Europe. (Medical Device Daily) Read More

Washington roundup: FDA's new nanoscale materials guidance sets bar at 1,000 nm

International report: Medical Care Technologies expands Chinese operations

Device gives hospitals early sense of patient's condition

Financings roundup: UHS to offer $175M of second lien toggle notes

Med-Tech Notes

Agreements/contracts: pSivida amends glaucoma R&D development with Pfizer

HIT roundup: Premier releases PhysicianFocus for performance improvement

Patent watch: Biomoda expands use of assay with new patent

Grants roundup: Precision Medical receives QTDP grant for UI device

Product Briefs

People in the News

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Virtual IPO word with stock graph and arrow

Parabilis takes top spot, pricing largest biopharma IPO at $670M

BioWorld

Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...